湖北省宜昌市新型冠状病毒肺炎治疗验案2则  

Analysis of 2 cases of COVID-19 in Yichang Hubei Province

作　　者：许若缨 陈家卫[1] 张晶[1] 明全 黄铭涵[1] XU Ruoying;CHEN Jiawei;ZHANG Jing;MING Quan;HUANG Minghan(The Second People's Hospital,Fujian University of Traditional Chinese Medicine,Fuzhou 350003,China;The Third People's Hospital of Yichang,Yichang 443003,China)

机构地区：[1]福建中医药大学附属第二人民医院,福建福州350003 [2]湖北省宜昌市第三人民医院,湖北宜昌443003

出　　处：《中国民族民间医药》2020年第20期84-87,共4页Chinese Journal of Ethnomedicine and Ethnopharmacy

基　　金：福建省教育厅中青年教师教育科研项目(JAT190278)。

摘　　要：结合2则在湖北省宜昌市抗疫期间的临床验案,分析中医药参与新冠肺炎治疗的优势及意义。在整体观及辨证论治思想的指导下,中医药参与新冠肺炎的治疗,早期干预可扭转病势发展,后期介入可促进痊愈,预防病情复发。Combined with two clinical trials from support the anti-epidemic period in Yichang,the advantages and significance of Chinese medicine participating in the treatment of COVID-19 were analyzed.Under the guidance of a holistic view and dialectical thinking,if Chinese medicine participates in the treatment of COVID-19,early intervention will reverse the development of the disease,and later intervention will promote healing and prevent recurrence.

关 键 词：湖北省宜昌市 新型冠状病毒肺炎 中医药治疗 验案 

分 类 号：R249[医药卫生—中医临床基础]